Vitamin D Receptor rs731236 Polymorphism Modulates Cancer Cachexia Susceptibility and Overall Survival: A Real-World Study on Context-Dependent Vitamin D Signalling
International Journal of Molecular Sciences · 27.06.2026 · 27 (13) · 5816
DOI: 10.3390/ijms27135816 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.06.2026. Verfasst von Valéria Tavares und 10 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology and Viral Pathology Group, IPO Porto Research Centre (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)/Department of P…. Hauptthemen laut MEDLINE: Cachexia, Receptors, Calcitriol, Polymorphism, Single Nucleotide, Genetic Predisposition to Disease. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: IPO Porto, Centre for the Research and Technology of Agro-Environmental and Biological Sciences, and Institute for Innovation, Capacity Building and Sustainability of Agri-Food Production.
Abstract (Originalsprache)
Cancer-associated cachexia (CAC) is a complex metabolic syndrome characterised by progressive skeletal muscle loss, systemic inflammation, reduced treatment tolerance, and poor survival. Marked interindividual variability in CAC susceptibility suggests that host genetic factors may contribute to its development. Vitamin D plays an important role in muscle metabolism and inflammatory control through activation of the vitamin D receptor (VDR). VDR signalling influences myogenesis, mitochondrial function, insulin-like growth factor pathways, and pro-inflammatory cytokine expression, all of which are implicated in CAC pathogenesis. Hence, VDR variants, including the rs731236 (A>G) polymorphism, which modifies receptor activity, may affect CAC pathogenesis. Thus, this study investigated the association between the polymorphism and susceptibility to CAC as well as patient survival in a cohort of 140 adult cancer patients. Briefly, the rs731236 GG genotype was significantly associated with a lower prevalence of CAC across disease diagnostic approaches (chi-square tests, p < 0.05). Furthermore, GG genotype carriers demonstrated significantly improved survival compared with carriers of AA/AG genotypes (Log-rank and Tarone–Ware tests, p < 0.05). In summary, these findings suggest that the rs731236 polymorphism influences both susceptibility to CAC and survival outcomes in patients with cancer, further supporting a clinically relevant role for vitamin D signalling in supportive oncology care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Oncology and Viral Pathology Group, IPO Porto Research Centre (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)/Department of Pathology and Laboratory Medicine/RISE-Associate Laboratory (Health Res…
- Research Department, Portuguese League Against Cancer (NRNorte), 4200-172 Porto, Portugal.
- School of Medicine and Biomedical Sciences (EMCB), Fernando Pessoa University, 4420-096 Gondomar, Portugal.
- Faculty of Medicine, University of Porto (FMUP), 4200-072 Porto, Portugal.
- Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal.
- Day Hospital, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
ORCID-Profile: Valéria Tavares, Ana Carolina Leão Silva, Anna Flávia Xavier, Tiago Ferreira, Joana M O Santos, Rui Medeiros
Förderung
- IPO Porto
- Centre for the Research and Technology of Agro-Environmental and Biological Sciences
- and Institute for Innovation, Capacity Building and Sustainability of Agri-Food Production
- Portuguese League Against Cancer - Northern Branch
- Fundação para a Ciência e Tecnologia
- Portuguese Institute of Oncology of Porto
- Institute for Innovation, Capacity Building and Sustainability of Agri-Food Production
- Portuguese League Against Cancer—Northern Branch
Zitieren
APA
Tavares, V., Silva, A. C. L., Xavier, A. F., de Melo, I. G., Ferreira, T., Pires, M. M., Silva, C., Dias, V. R., Silva, M. P., Santos, J. M. O., & Medeiros, R. (2026). Vitamin D Receptor rs731236 Polymorphism Modulates Cancer Cachexia Susceptibility and Overall Survival: A Real-World Study on Context-Dependent Vitamin D Signalling. International Journal of Molecular Sciences, 27(13), 5816. https://doi.org/10.3390/ijms27135816
Vancouver
Tavares V, Silva ACL, Xavier AF, de Melo IG, Ferreira T, Pires MM, et al. Vitamin D Receptor rs731236 Polymorphism Modulates Cancer Cachexia Susceptibility and Overall Survival: A Real-World Study on Context-Dependent Vitamin D Signalling. International Journal of Molecular Sciences. 2026;27(13):5816. doi:10.3390/ijms27135816
BibTeX
@article{Tavares2026,
author = {Tavares, Valéria and Silva, Ana Carolina Leão and Xavier, Anna Flávia and de Melo, Inês Guerra and Ferreira, Tiago and Pires, Mariana Moreira and Silva, Cláudia and Dias, Virgínia Rocha and Silva, Maria Paula and Santos, Joana M O and Medeiros, Rui},
title = {Vitamin D Receptor rs731236 Polymorphism Modulates Cancer Cachexia Susceptibility and Overall Survival: A Real-World Study on Context-Dependent Vitamin D Signalling},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {5816},
doi = {10.3390/ijms27135816}
}
EUVIMED